Selected article for: "cardiovascular disease and International license"

Author: Michael P McRae; Glennon W Simmons; Nicolaos J Christodoulides; Zhibing Lu; Stella K Kang; David Fenyo; Timothy Alcorn; Isaac P Dapkins; Iman Sharif; Deniz Vurmaz; Sayli S Modak; Kritika Srinivasan; Shruti Warhadpande; Ravi Shrivastav; John T McDevitt
Title: Clinical Decision Support Tool and Rapid Point-of-Care Platform for Determining Disease Severity in Patients with COVID-19
  • Document date: 2020_4_22
  • ID: h4lsvgxo_39
    Snippet: Selection of the biomarkers targeted for the development of this COVID-19 Severity Score was based on the following process/criteria and summarized in Table 1 . Biomarkers were identified as relevant to complications associated with COVID-19 including those associated with acute inflammation/infection (CRP) and various stages of the cardiovascular disease such as . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, .....
    Document: Selection of the biomarkers targeted for the development of this COVID-19 Severity Score was based on the following process/criteria and summarized in Table 1 . Biomarkers were identified as relevant to complications associated with COVID-19 including those associated with acute inflammation/infection (CRP) and various stages of the cardiovascular disease such as . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cardiovascular disease and cc NC ND International license: 1, 2, 3, 4, 5, 6
    • cardiovascular disease and CRP infection: 1
    • cardiovascular disease and International license: 1, 2, 3, 4, 5, 6
    • cc NC ND International license and CRP infection: 1
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and Severity Score development: 1
    • CRP infection and inflammation CRP infection: 1, 2, 3
    • CRP infection and International license: 1
    • International license and Severity Score development: 1